Market overview
The global epilepsy monitoring devices market is worth USD 942 mn in 2026 and is forecast to reach USD 1.9 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Video-EEG systems is the largest by product segment.
| Scope | Systems for recording and detecting seizures: video-EEG monitoring systems, ambulatory EEG, wearable seizure detectors and rapid-EEG headsets for intensive care. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 880 mn |
| Value 2026 | USD 942 mn |
| Value 2036 | USD 1.9 bn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 55.4 thousand units |
| Volume 2036 | 109 thousand units |
| Average price 2026 | USD 17,010 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Epilepsy Monitoring Devices market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 942 mn |
| 2027 | USD 1.0 bn |
| 2028 | USD 1.1 bn |
| 2029 | USD 1.2 bn |
| 2030 | USD 1.3 bn |
| 2031 | USD 1.4 bn |
| 2032 | USD 1.5 bn |
| 2033 | USD 1.6 bn |
| 2034 | USD 1.7 bn |
| 2035 | USD 1.8 bn |
| 2036 | USD 1.9 bn |
Epilepsy Monitoring Devices market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Video-EEG systems | 44.0% | 32.3% | USD 414 mn | 4.2% |
| Ambulatory EEG | 24.0% | 21.3% | USD 226 mn | 6.2% |
| Wearable seizure detectors | 18.0% | 25.1% | USD 169 mn | 11.1% |
| Rapid-EEG headsets | 14.0% | 21.3% | USD 132 mn | 12.1% |
By setting
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Epilepsy monitoring units | 40.0% | 31.4% | USD 377 mn | 4.9% |
| Intensive care | 30.0% | 31.2% | USD 282 mn | 7.9% |
| Home and ambulatory | 30.0% | 37.4% | USD 282 mn | 9.9% |
By monitoring duration
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Routine and short-term | 30.0% | 26.0% | USD 282 mn | 6.0% |
| Long-term inpatient | 34.0% | 30.0% | USD 320 mn | 6.2% |
| Ambulatory and continuous | 36.0% | 44.0% | USD 339 mn | 9.7% |
By patient age group
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Adults | 58.0% | 56.0% | USD 546 mn | 7.1% |
| Children | 28.0% | 28.0% | USD 264 mn | 7.5% |
| Neonates and infants | 14.0% | 16.0% | USD 132 mn | 8.9% |
By seizure type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Focal | 54.0% | 53.0% | USD 508 mn | 7.3% |
| Generalised | 34.0% | 34.0% | USD 320 mn | 7.5% |
| Unclassified | 12.0% | 13.0% | USD 113 mn | 8.4% |
Top 25 countries for epilepsy monitoring devices by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.5% of 2026 revenue and the 25 countries below together hold 95.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 339 mn | 36.0% | USD 693 mn | 7.4% |
| 2 | China | USD 113 mn | 12.0% | USD 278 mn | 9.4% |
| 3 | Germany | USD 66 mn | 7.0% | USD 122 mn | 6.4% |
| 4 | Japan | USD 66 mn | 7.0% | USD 116 mn | 5.9% |
| 5 | United Kingdom | USD 47 mn | 5.0% | USD 91 mn | 6.8% |
| 6 | France | USD 38 mn | 4.0% | USD 70 mn | 6.4% |
| 7 | Italy | USD 28 mn | 3.0% | USD 50 mn | 6.0% |
| 8 | Canada | USD 28 mn | 3.0% | USD 54 mn | 6.8% |
| 9 | India | USD 28 mn | 3.0% | USD 76 mn | 10.4% |
| 10 | Brazil | USD 24 mn | 2.5% | USD 52 mn | 8.3% |
| 11 | South Korea | USD 14 mn | 1.5% | USD 27 mn | 6.9% |
| 12 | Spain | USD 12 mn | 1.3% | USD 24 mn | 7.0% |
| 13 | Australia | USD 12 mn | 1.3% | USD 24 mn | 7.0% |
| 14 | Netherlands | USD 8.7 mn | 0.9% | USD 17 mn | 7.0% |
| 15 | Mexico | USD 8.7 mn | 0.9% | USD 21 mn | 9.4% |
| 16 | Turkey | USD 8.7 mn | 0.9% | USD 21 mn | 9.4% |
| 17 | Russia | USD 8.7 mn | 0.9% | USD 17 mn | 7.0% |
| 18 | Taiwan | USD 8.7 mn | 0.9% | USD 17 mn | 7.0% |
| 19 | Switzerland | USD 7.0 mn | 0.7% | USD 14 mn | 6.9% |
| 20 | Poland | USD 7.0 mn | 0.7% | USD 14 mn | 6.9% |
| 21 | Belgium | USD 5.2 mn | 0.6% | USD 10 mn | 7.1% |
| 22 | Saudi Arabia | USD 5.2 mn | 0.6% | USD 13 mn | 9.5% |
| 23 | Sweden | USD 5.2 mn | 0.6% | USD 10 mn | 7.1% |
| 24 | Thailand | USD 5.2 mn | 0.6% | USD 13 mn | 9.5% |
| 25 | Austria | USD 5.2 mn | 0.6% | USD 10 mn | 7.1% |
| Rest of world | USD 43 mn | 4.6% | USD 85 mn | 7.0% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Natus Medical
- Nihon Kohden
- Compumedics
Group 2: Regional and specialist players
- Cadwell
- Ceribell
- Neurosoft
- Brain Products
- EB Neuro
- Micromed
- Deymed Diagnostics
- Ad-Tech Medical
Group 3: Emerging and niche players
- Empatica
- Epitel
- Byteflies
- UNEEG medical
- LivAssured
- Brain Sentinel
- Epilog
- Bioserenity
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the epilepsy monitoring devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by product, by setting, by monitoring duration, by patient age group, by seizure type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the epilepsy monitoring devices market?
The global epilepsy monitoring devices market is estimated at USD 880 mn in 2025 and USD 942 mn in 2026.
How fast will the epilepsy monitoring devices market grow?
It is forecast to reach USD 1.9 bn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 999 mn.
Which country is the largest market for epilepsy monitoring devices?
United States is the largest market by revenue at USD 339 mn in 2026, 36.0% of the global total. The three largest countries together hold 55.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.4% a year from 2026 to 2036.
Which epilepsy monitoring devices segment is largest?
In the by product split, Video-EEG systems is the largest segment with 44.0% of 2026 revenue.
Who are the leading epilepsy monitoring devices companies?
Global leaders include Natus Medical, Nihon Kohden, Compumedics.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Robotic Catheterization SystemsUSD 944 mn · 15.0% CAGR
- Glioblastoma Treatment DrugsUSD 945 mn · 5.5% CAGR
- Virus InactivationUSD 935 mn · 10.0% CAGR
- Early Pulmonary Embolism Thrombectomy DeviceUSD 935 mn · 12.0% CAGR
- Radiotherapy Positioning DevicesUSD 933 mn · 5.8% CAGR
- Biosafety CabinetUSD 958 mn · 7.0% CAGR
- Digital Twins TechnologiesUSD 967 mn · 21.0% CAGR
- Peptide Receptor Radionuclide Therapy (PRRT)USD 913 mn · 8.0% CAGR
← Eosinophilic Esophagitis Extended-Action Local Anaesthetic →